International Stem Cell Corp. (ISCO) Applying Stem Cell Therapies to 3 Untreatable Diseases
International Stem Cell is a California-based biotech company developing novel stem cell-based therapies for the treatment of diseases of the brain, liver, and the eye. ISCO’s main focus is on three therapeutic areas where it has recognized significant clinical need for a cell-based approach to treatment. Parkinson’s disease – Parkinson's disease is the second most common neurodegenerative disease in the United States. ISCO believes that the origin of the disease and the relative localization in the brain make Parkinson’s an attractive target for stem cell therapy. ISCO Solution: ISCO scientists are focused on deriving neuronal cells and have developed a…